Daniel Bergman

In my current research, I investigate the reproductive timing in small mammals, including mountain hare (Lepus timidus), brown hare (Lepus europaeus), badger (Meles meles), red fox (Vulpes vulpes), beaver (Castor fiber), polecat (Mustela putorius) and pine marten (Martes martes). We are using dissections, hormone analysis and citizen science to delineate the timing of their reproductive seasons. The results will inform the regulation of the hunting seasons for these species.

To date, my research has primarily focused on reproductive endocrinology, but I have a varied background in clinical and anatomic pathology, food safety and laboratory animal science. The common denominator in all my work is the connection between human, animal and environmental health. In parallel with my postdoctoral research, I am supplementing my education with a One Health Master's degree at the University of Alaska Fairbanks.

• PhD student, Department of Clinical Sciences, Swedish University of Agricultural Sciences, 2016–2020
• Veterinary pathologist, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, 2020–2021
• Research fellow, Obihiro University of Agriculture and Veterinary Medicine, Japan, 2022
• Laboratory animal veterinarian, Karolinska University Hospital, 2022–2024
• Postdoctoral researcher, Department of Clinical Sciences, Swedish University of Agricultural Sciences, 2024–2026

Education

• Doctor of Veterinary Medicine (DVM), Swedish University of Agricultural Sciences, 2015
• Doctor of Philosophy (PhD), Veterinary medicine science, Swedish University of Agricultural Sciences, 2020
• One Health Master (OHM), University of Alaska Fairbanks, USA, 2022–

Hallberg, I., Olsson, H., Lau, A., Wallander, S., Snell, A., Bergman, D., Holst, BS. (2024), Endocrine and dog factors associated with semen quality. Sci Rep. 14, 718. https://doi.org/10.1038/s41598-024-51242-0

Dong, B., Bergman, D., Holst, BS. (2021), Prevalence of heterophilic antibodies in serum samples from horses in an equine hospital, and elimination of interference using chicken IgY. Acta Vet Scand. 63, 1.0. https://doi.org/10.1186/s13028-021-00575-1

Bergman, D., Bäckström, C., Hansson-Hamlin, H., Larsson, A., Holst, BS. (2020), Pre-existing canine anti-IgG antibodies: implications for immunotherapy, immunogenicity testing and immunoassay analysis. Sci Rep. 10, 12696. https://doi.org/10.1038/s41598-020-69618-3

Bergman, D., Larsson, A., Hansson-Hamlin, H., Holst BS. (2019), Characterization of canine anti-mouse antibodies highlights that multiple strategies are needed to combat immunoassay interference. Sci Rep. 9: 14521. https://doi.org/10.1038/s41598-019-51228-3

Bergman D., Larsson A, Hansson-Hamlin H., Ström Holst B. (2019), Investigation of interference from canine anti-mouse antibodies in hormone immunoassays. Vet Clin Pathol., 48(Suppl. 1): 59–69. https://doi.org/10.1111/vcp.12764

Bergman D., Larsson A., Hansson-Hamlin H., Svensson A., Holst BS. (2018), Prevalence of interfering antibodies in dogs and cats evaluated using a species-independent assay. Vet Clin Pathol., 47: 205–212. https://doi.org/10.1111/vcp.12612

Nordin, M., Bergman, D., Halje, M., Engström, W., Ward, A. (2014), Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif., 47: 189-199. https://doi.org/10.1111/cpr.12106

Halje, M., Nordin, M., Bergman, D., Wengström, W. (2012), The Effect of Insulin-like Growth Factor II in the Regulation of Tumour Cell Growth In Vitro and Tumourigenesis In Vivo. In Vivo, 26 (4): 519–526. 

Bergman, D., Halje, M., Nordin, M., Engström, W. (2012), Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review. Gerontology, 59 (3): 240–249. https://doi.org/10.1159/000343995

Google Scholar